Bengaluru-based biotechnology startup CrisprBits has secured USD 3 million in a Pre-Series A round led by Spectrum Impact, the family office of Rajendra Gogri, Chairman and Managing Director of Aarti Industries. The latest infusion places the company’s valuation at USD 12 million.
The round saw continued support from existing investor Vijay Alreja Family Office of VJ Technologies Group, alongside participation from new investors from the promoter family of HBL Engineering. Previously, CrisprBits had raised capital from its founders, VJ Technologies Group, and C-CAMP.
The startup plans to deploy the fresh funds to scale commercialisation of its PathCrisp molecular diagnostics platform and expand manufacturing capacity for its human health, food safety and animal health test portfolio.
Founded by Vijay Chandru, Sunil Arora, Rajeev Kohli, Bharat Jobanputra and Aditya Sarda, CrisprBits operates a 7,300 sq. ft. CRISPR research and prototype development facility in Bengaluru. Its platforms span multiple verticals, including PathCrisp for diagnostics, EdiCrisp for gene editing and strain engineering, and CurieCrisp for preclinical and rare disease therapeutics.
Over the next six months, the company aims to enter global markets, particularly Africa and Latin America, with its diagnostic products, while also strengthening capacity at its manufacturing facility.
Also Read